Glenmark Pharmaceuticals’s consolidated net profit clocks in growth of 23% in Q1

26 Jul 2011 Evaluate

Glenmark Pharmaceuticals has reported results for the quarter ended June 30, 2011.

The company‘s net profit has registered growth of 19.20% at Rs 72.46 crore for the quarter as compared to Rs 60.79 crore for the corresponding quarter of the previous year. Its total income has increased by 19.14% at Rs 330.78 crore for the Q1FY12 from Rs 277.62 crore for the Q1FY11.

On consolidated basis, the group’s net profit for the quarter ended June 30, 2011 has clocked in 23.20% growth at Rs 210.11 crore as compared to Rs 170.54 crore for the June quarter of the previous fiscal. Its total income has increased by 26.77% to Rs 880.80 crore for the quarter from Rs 694.81 crore for the June quarter of FY11.

Glenmark Pharma Share Price

1043.00 0.00 (0.00%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.